Human Liver Homogenate
-
+
Specifications
- 1 ml at 20 mg/ml
- Contains both Phase I and Phase II enzymes
- Native cofactors and subcellular components retained
Description
Our human liver homogenate offers a comprehensive in vitro system for evaluating both Phase I and Phase II metabolic pathways, enabling broad applications in drug metabolism, enzyme activity profiling, and biotransformation studies. Derived from human liver tissue, this homogenate preserves the full complement of hepatic enzymes and cofactors, providing a physiologically relevant model for early-stage screening and mechanistic research.
Prepared under controlled conditions to ensure consistency and integrity, our human liver homogenate is ideal for applications requiring whole-liver enzymatic activity, including metabolic stability testing, conjugation reactions, and exploratory toxicology.
